Abstract:Influenza virus RNA-dependent RNA polymerase consists of three viral protein subunits: PA, PB1, and PB2. Protein- protein interactions (PPIs) of these subunits play pivotal roles in assembling the functional polymerase complex, which is essential for the replication and transcription of influenza virus RNA. Here we developed a highly specific and robust bimolecular luminescence complementation (BiLC) reporter system to facilitate the investigation of influenza virus polymerase complex formation. Furthermore, by combining computational modeling and the BiLC reporter assay, we identified several novel small-molecule compounds that selectively inhibited PB1-PB2 interaction. Function of one such lead compound was confirmed by its activity in suppressing influenza virus replication. In addition, our studies also revealed that PA plays a critical role in enhancing interactions between PB1 and PB2, which could be important in targeting sites for anti-influenza intervention. Collectively, these findings not only aid the development of novel inhibitors targeting the formation of influenza virus polymerase complex but also present a new tool to investigate the exquisite mechanism of PPIs.IMPORTANCE Formation of the functional influenza virus polymerase involves complex protein-protein interactions (PPIs) of PA, PB1, and PB2 subunits. In this work, we developed a novel BiLC assay system which is sensitive and specific to quantify both strong and weak PPIs between influenza virus polymerase subunits. More importantly, by combining in silico modeling and our BiLC assay, we identified a small molecule that can suppress influenza virus replication by disrupting the polymerase assembly. Thus, we developed an innovative method to investigate PPIs of multisubunit complexes effectively and to identify new molecules inhibiting influenza virus polymerase assembly.

Establishment of a High-Throughput Assay to Monitor Influenza A Virus RNA Transcription and Replication

Rapid Detection of Influenza A Viruses Using a Real-Time Reverse Transcription Recombinase-Aided Amplification Assay.

Mrna Display with Library of Even-Distribution Reveals Cellular Interactors of Influenza Virus NS1

A cell-based screening system for influenza A viral RNA transcription/replication inhibitors

Application of an In-Cell Western assay for measurement of influenza A virus replication.

A Simple And Robust Approach For Evaluation Of Antivirals Using A Recombinant Influenza Virus Expressing Gaussia Luciferase

Development of an HiBiT-tagged Reporter H3N2 Influenza A Virus and Its Utility As an Antiviral Screening Platform

High-Throughput cell-based immunofluorescence assays against influenza

A Parallel Phenotypic Versus Target-Based Screening Strategy For Rna-Dependent Rna Polymerase Inhibitors Of The Influenza A Virus

An Interferon-Beta Promoter Reporter Assay for High Throughput Identification of Compounds Against Multiple RNA Viruses

Establishment of a rapid ELISPOT assay for influenza virus titration and neutralizing antibody detection

High-throughput investigation of genetic design constraints in domesticated Influenza A Virus for transient gene delivery

A reporter system for assaying influenza virus RNP functionality based on secreted Gaussia luciferase activity

Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening.

Establishing a Safe, Rapid, Convenient and Low-Cost Antiviral Assay of Interferon Bioactivity Based on Recombinant VSV Expressing GFP.

Development and application of bioluminescence imaging for the influenza A virus

High-Throughput Screening for Anti–Influenza A Virus Drugs and Study of the Mechanism of Procyanidin on Influenza A Virus–Induced Autophagy

Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by A Bimolecular Luminescence Complementation-Based Reporter System

Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays

Enhanced detection of infectious airborne influenza virus

Novel, Real-Time Cell Analysis for Measuring Viral Cytopathogenesis and the Efficacy of Neutralizing Antibodies to the 2009 Influenza A (h1n1) Virus